Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function

Recruiting N/A Interventional Study
Atopic Dermatitis (AD)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Day – 14 Days
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
400 (estimated)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main purpose of this study is to assess the efficacy of a partially hydrolyzed formula with synbiotics in halting one of the first steps of the allergic march (atopic dermatitis) in infants at risk of allergy. Other efficacy and safety parameters will be assessed as well.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Written informed consent has been obtained from at least one parent or legally acceptable representative (LAR), if applicable 2. Infant gestational age ≥ 37 completed weeks 3. Infant birth weight of ≥ 2.5 kg and ≤ 4.5 kg 4. Infant postnatal age ≤ 14 days (date of birth = day …
Contacts

Amelie Goyer, PhD

+41217858939

Amelie.Goyer1@rd.nestle.com

CONTACT